Search results
Amylyx Pharmaceuticals' Investigational Drug Shows Improved Pancreatic Function In Patients With...
Benzinga via Yahoo Finance· 1 month agoWednesday, Amylyx Pharmaceuticals Inc (NASDAQ:AMLX) released interim data from the ongoing Phase 2...
Amylyx (AMLX) Doses First Patient in Wolfram Syndrome Study
Zacks via Yahoo Finance· 1 year agoAmylyx Pharmaceuticals, Inc. AMLX announced that the first participant has been dosed in the HELIOS...
Amylyx Stock Wipes Out Nearly All Of Its Value, Crashing 82%, After Pivotal ALS Drug Failure
Investor's Business Daily· 2 months agoAmylyx stock crashed Friday, losing almost all of its value, after the company said its approved ALS...
Amylyx (AMLX) Withdraws ALS Drug, Cuts Workforce by 70%
Zacks via Yahoo Finance· 1 month agoAmylyx (AMLX) makes a formal decision to remove its amyotrophic lateral sclerosis drug from the U.S....
ALS drug pulled from market in US, Canada after trial shows it doesn't work
Euronews via Yahoo News· 1 month agoThe pharmaceutical company behind a drug for amyotrophic lateral sclerosis (ALS) said it would start...
Amylyx Stock Rockets As ALS Drug Tacks On Another Triple-Digit Quarter
Investor's Business Daily· 3 months agoSales of Amylyx Pharmaceuticals' ALS drug, Relyvrio, beat Wall Street's fourth-quarter expectations...
Amylyx Pharmaceuticals Inc (AMLX) Reports Robust Revenue Growth and Net Income for Full Year 2023
GuruFocus.com via Yahoo Finance· 3 months agoNet Product Revenue: Amylyx Pharmaceuticals Inc (NASDAQ:AMLX) reported a significant increase in net...
The Zacks Analyst Blog Highlights Bristol Myers, Moderna, 2seventy bio, Amylyx Pharmaceuticals and...
Zacks via Yahoo Finance· 4 weeks agoFor Immediate Release Chicago, IL – April 12, 2024 – Zacks.com announces the list of stocks featured...
ALS drug Relyvrio withdrawn from market after failed clinical trial
CNN via Yahoo News· 1 month agoAmylyx Pharmaceuticals announced Thursday that it has begun the process of voluntarily withdrawing...
Amylyx ALS drug fails crucial study, putting company’s future in doubt
BioPharma Dive via Yahoo Finance· 2 months agoThe results have led Amylyx to pause promotion of Relyvrio and potentially pull it from the market...